APT1 is upregulated in NSCLC cells, and inhibition of APT1 suppresses cell proliferation, migration, and invasion, supporting an oncogenic activity of APT1 [17], which also raises the possibility that APT1 promotes NSCLC progression via depalmitoylation. The gene discussed is LYPLA1; the disease is non-small cell lung carcinoma.